Bio-Matrix Takes Step toward Setting Up Adipose Tissue-Derived Stem Cell Bank
Validation Systems will help firm finalize FDA cGMP quality systems.
Bio-Matrix Scientific Group signed a contract with Validation Systems to hasten the cryogenic storage of stem cells. Validation Systems will help the company complete and finalize its FDA cGMP quality systems documentation. Bio-Matrix reports that once it is finalized and clearance from the State of California is received, stem cell specimens can be cryogenically stored.
Bio-Matrix says it intends to open what it believes to be the first commercial adult stem cell processing and banking facility in the world for harvesting stem cells from adipose tissue.
Bio-Matrix’ new 15,000-sq-ft facility will house the company’s secure Cryogenic Stem Cell Bank, three research labs, aseptic cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology, and flow cytometry laboratories.